The electronic psoriasis and arthritis screening questionnaire (ePASQ): A sensitive and specific tool to diagnose psoriatic arthritis patients

Journal of Cutaneous Medicine and Surgery

Volumn 15, Issue 3, 2011, Pages 143-149

  Khraishi, Majed ^a   Mong, Jonathan ^a   Mugford, Gerry ^a   Landells, Ian ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC PSORIASIS AND ARTHRITIS SCREENING QUESTIONNAIRE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79956048725     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2011.10018     Document Type: Article

References (16)

1. Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64 Suppl 2:ii14-7, doi:10.1136/ard.2004.032482.
2. Stern RS. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985;12:315-20. (Pubitemid 15025376)
3. Peters JP, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondyloarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92, doi:10.1016/j.semarthrit.2004.07.010. (Pubitemid 39643120)
4. Morgan C, Lunt M, Bunn D, et al. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis. Rheumatology 2007;46:1819-23, doi:10.1093/rheumatology/kem270. (Pubitemid 350168298)
5. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73, doi:10.1002/art.21972. (Pubitemid 44205029)
6. Gladman DD, Mease PJ, Healy P, et al. Outcome measures in psoriatic arthritis. J Rheumatol 2007;34:1159-66. (Pubitemid 46774867)
7. Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009; 68:1387-94, doi:10.1136/ard.2008. 094946.
8. Mease PJ, Ory P, Sharp JT, et al. Adalimumab for long-term treatment of psoriatic arthritis: two-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis 2009;68:702-9, doi:10.1136/ard.2008.092767.
9. Antoni CE, Kavanaugh A, van der Heijde D, et al. Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). J Rheumatol 2008;35:869-76. (Pubitemid 351747130)
10. Peloso PM, Behl M, Hull P, Reeder B. The Psoriasis and Arthritis Questionnaire (PAQ) in detection of arthritis in patients with arthritis. Arthritis Rheum 1997;40 Suppl 9:S64.
11. Ibrahim GH, Buch MH, Lawson R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009;27:469-74.
12. Husni ME, Meyer KH, Cohen DS, et al. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007;57:581-7, doi:10.1016/j.jaad.2007.04.001. (Pubitemid 47384917)
13. Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009;68:497-501, doi:10.1136/ard.2008.089441.
14. Khraishi M, Landells I, Mugford G. The self-administered Psoriasis and Arthritis Screening Questionnaire (PASQ): a sensitive and specific tool for the diagnosis of early and established psoriatic arthritis. Psoriasis Forum 2010;16:9-16.
15. Khraishi M, Landells I, Heale C, et al. The Psoriasis and Arthritis Screening Questionnaire (PASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients with high correlation to the CASPAR criteria. Ann Rheum Dis 2008;67 Suppl ll:527.
16. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78, doi:10.1016/0049-0172(73)90035-8.